These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 32930121

  • 1. Nestin is significantly associated with the overall survival of nonsmall cell lung cancer: A meta-analysis.
    Zhang D, Wang J.
    J Cancer Res Ther; 2020; 16(4):800-803. PubMed ID: 32930121
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z, Shen W.
    Oncotarget; 2017 Apr 18; 8(16):27137-27144. PubMed ID: 28404927
    [Abstract] [Full Text] [Related]

  • 6. Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer.
    Zhang X, Tian T, Sun W, Liu C, Fang X.
    Medicine (Baltimore); 2017 Jun 18; 96(26):e7346. PubMed ID: 28658153
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z, Wu RR, Lv L, Li P, Zhang LY, Hao QL, Li W.
    Int J Clin Exp Pathol; 2014 Jun 18; 7(7):3632-46. PubMed ID: 25120740
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.
    Wang X, Zhao H, Lv L, Bao L, Wang X, Han S.
    Sci Rep; 2016 Jan 12; 6():19239. PubMed ID: 26754405
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX, Zhang S, Yuan SJ, Wang W, Yu J.
    World J Surg Oncol; 2016 Sep 02; 14(1):237. PubMed ID: 27589869
    [Abstract] [Full Text] [Related]

  • 13. Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis.
    Raphael J, Batra A, Boldt G, Shah PS, Blanchette P, Rodrigues G, Vincent MD.
    Clin Lung Cancer; 2020 Mar 02; 21(2):106-113.e5. PubMed ID: 31992521
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Li S, Lai Y, Fan J, Shen C, Che G.
    Clin Exp Med; 2017 May 02; 17(2):161-174. PubMed ID: 27099933
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S, Qiu Z, He J, Li L, Li W.
    Int J Clin Exp Pathol; 2014 May 02; 7(10):6694-704. PubMed ID: 25400749
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X, Huang G, Zhang J, Zhang L, Liang Z.
    PLoS One; 2020 May 02; 15(10):e0240321. PubMed ID: 33052949
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.
    Drzewiecka H, Jarmołowska-Jurczyszyn D, Kluk A, Gałęcki B, Dyszkiewicz W, Jagodziński PP.
    Int J Oncol; 2020 Jun 02; 56(6):1352-1372. PubMed ID: 32236582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.